Place |
Biozentrum |
Time |
9:00 - ca. 17:30, with a lunch break from ca. 12:30 - 14:00 |
|
Module |
Date |
Topic |
1 |
11. Feb. 2008, lecture hall H2
12. Feb. 2008, room NU100/015 |
Basics in drug development, production and approval (Dr. Andreas Franken,
Prof. Harald Schweim, Dr. Bettina Klug,
Dr. Christa Schröder) |
2 |
28. Feb. 2008, room NU100/015
6. March 2008, room NU100/015 |
Genomics, proteomics and pharmacogenomics in target identification (Prof. Dieter Steinhilber,
Prof. Jochen Klein, Prof. Michael Karas) |
3 |
02. April 2008, room N100/015, 13:00 - ca. 17:00/17:30
CANCELED ! |
Lead identification and optimisation |
04. April 2008, room NU100/015 + BCC
14:00 - ca. 17:30
|
Lead identification and optimisation
(Prof. Gisbert Schneider) |
08. April 2008 (Excursion to the Bayer Research Centre, Wuppertal)
Departure 6:15 Biozentrum,
Main Entrance |
Visit of FIRST PDF download |
12. April 2008,
room NU100/114,
9:00 - ca. 12:30 |
Lead identification and optimisation (Dr. Tania Weil) |
4 |
26. September 2008 & 27. September 2008
26.09.08 (Fri.): 10:30 - ca. 17:00
27.09.08 (Sat.): 9:00 - ca. 17:00
GSH lecture hall
|
Patent law & Project management
(Dr. Alexander Alexandrov, Dr. Schilling) |
5 |
29. September 2008 & 30. September 2008
Room NU100, 114 |
GLP, GMP and quality control
(Dr. Dirk Krumme, Dr. Rudolf Völler) |
6 |
17. March 2009, B2
18. March 2009, B2 |
Pharmacodynamics, Pharmacokinetics
(Prof. Jochen Klein, Dr. Martina Zimmermann) |
7 |
28. September 2009, Uniklinikum, House 74, 4th floor seminar room2 |
Preclinical pharmacology and toxicology, animal models |
8 |
29. September 2009, NU100/015 |
Basics in clinical trials management: Drug Development |
9 |
27.July 2010, B3 |
Advanced clinical trials management: Drug Safety & Pharmacovigilance |
10 |
01. October 2009, lecture hall H1 and Beilstein Computer Cluster (BCC) + 1 day (date to be set) |
Advanced biostatistics |
11 |
30. September 2009 |
Regulatory affairs |
12 |
09. October 2010, GRADE office, Riedbergplatz1 , 4th floor |
Business plan, marketing and international trends in drug markets (Dr. Beate Sidau) |
